Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATNX
4301
DELISTED
Athenex, Inc. Common Stock
ATNX
| $2.03M | ﹤0.01% |
5,120
-4,330
| -46% | -$1.2M |
|
4302
Asbury Automotive
ABG
$3.78B
| $2.03M | ﹤0.01% |
24,013
+4,512
| +23% | +$352K |
|
|
INN
4303
Summit Hotel Properties
INN
$651M
| $2.03M | ﹤0.01% |
176,605
+129,545
| +275% | +$1.53M |
|
4304
PUT
Banc of California
BANC
$3.13B
| $2.02M | ﹤0.01% |
144,900
-48,600
| -25% | -$686K |
|
4305
PUT
Cinemark Holdings
CNK
$4.33B
| $2.02M | ﹤0.01% |
56,000
+45,300
| +423% | +$1.79M |
|
4306
CALL
Invesco Senior Loan ETF
BKLN
$6.76B
| $2.02M | ﹤0.01% |
89,100
-224,300
| -72% | -$5.11M |
|
4307
Center Bancorp
CNOB
$1.79B
| $2.02M | ﹤0.01% |
89,097
+24,408
| +38% | +$526K |
|
4308
PUT
OSI Systems
OSIS
$3.76B
| $2.02M | ﹤0.01% |
17,900
+13,600
| +316% | +$1.37M |
|
4309
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.64B
| $2.02M | ﹤0.01% |
32,892
-17,984
| -35% | -$1.08M |
|
4310
PUT
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$39.8M
| $2.01M | ﹤0.01% |
559
+188
| +51% | +$792K |
|
4311
LivePerson
LPSN
$35.2M
| $2.01M | ﹤0.01% |
4,785
-1,088
| -19% | -$464K |
|
4312
PUT
PBF Energy
PBF
$8.52B
| $2.01M | ﹤0.01% |
64,200
-1,400
| -2% | -$41.8K |
|
4313
Direxion Daily Real Estate Bear 3X ETF
DRV
$25.3M
| $2.01M | ﹤0.01% |
6,107
+2,337
| +62% | +$788K |
|
4314
State Street SPDR S&P Capital Markets ETF
KCE
$480M
| $2.01M | ﹤0.01% |
36,200
+5,449
| +18% | +$302K |
|
4315
PUT
American Water Works
AWK
$27.1B
| $2.01M | ﹤0.01% |
17,300
-1,900
| -10% | -$210K |
|
4316
CALL
Ultragenyx Pharmaceutical
RARE
$2.61B
| $2.01M | ﹤0.01% |
31,600
+26,900
| +572% | +$1.71M |
|
|
4317
CALL
OSI Systems
OSIS
$3.76B
| $2M | ﹤0.01% |
17,800
+1,600
| +10% | +$161K |
|
|
MRNS
4318
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $2M | ﹤0.01% |
120,750
+111,025
| +1,142% | +$1.93M |
|
4319
AerCap
AER
$24B
| $2M | ﹤0.01% |
38,498
-39,569
| -51% | -$1.94M |
|
|
SC
4320
PUT
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $2M | ﹤0.01% |
83,500
+36,700
| +78% | +$817K |
|
4321
PUT
Under Armour Class C
UA
$2.26B
| $2M | ﹤0.01% |
90,100
-24,100
| -21% | -$501K |
|
|
ARNA
4322
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2M | ﹤0.01% |
34,100
+1,300
| +4% | +$67.2K |
|
4323
Glacier Bancorp
GBCI
$6.5B
| $2M | ﹤0.01% |
49,274
-16,139
| -25% | -$662K |
|
4324
CALL
RPM International
RPM
$14.5B
| $2M | ﹤0.01% |
32,700
+9,500
| +41% | +$561K |
|
4325
CALL
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
$18.6M
| $2M | ﹤0.01% |
4,740
+680
| +17% | +$307K |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.